DNA Economy: Using Genetic Information to Improve Health

Read Transcript

The DNA Economy in my mind is analyzing genetic information to answer key questions. And those questions may be related to food or water safety, they may be related to a crime scene investigation, they maybe related to health and wellness or propensity for a specific disease, or in my case it may be related to tumor characterization.

One of the biggest problems the drug company have is, when they discover a particular bio-marker that they hypothesize is going to be effective against a particular tumor type and a particular mutation, it's recruiting patients into a trial to verify. So, with the technology that we now have, to sequence the geno, we can take population of patients and screen them all, take that genetic information and categorize it and then match it up to different projects to with pharma and rather than its taking three years to recruit a pool of patients for a trial, we can now do it in a year.

So the value is the ability to recruit patients much more quickly because now we can characterize across the entire geno and then library that data, utilize other health information relative to that patient and then match it up to a specific drug trial, and the drug company that is about this, as we imagine.

But so the community based oncology clients who are seeing the majority these patients. It's an opportunity for them more quickly to get patients to get enrolled in trials. It's also an opportunity for them for a large degree to help them move these therapy developments along much more quickly, or purely from a business perspective, it seems to be erased to the bottom in terms of cost.

Everybody is so of quickly charted drive down costs, all of sudden these businesses, how viable are they? So, I think we need to be more responsible in how we manage the affordability, affordability is critically important. But raising to the bottom isn't necessarily the right way to go.

The right way to go is to demonstrate the health benefit to the pairs, and assure that the pairs understand the value and the health economic value of these technologies and then appropriately provide reimbursement support. That's number one. The second is the responsible utilization of this information.

Think about it, we're now understanding and characterizing people's genetic profile, and for years, people have worried and been concerned about that I think if we design programs to ensure the responsible use of that genetic information, our opportunity to impact health and well being is significant..